Infectious Diseases Completed Phase 1 Trials for Midazolam (DB00683)

Also known as: Infectious Disease

Indication	Status	Phase
DBCOND0028267 (Infectious Diseases)	Completed	1

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT01275170	A Single-Dose Study to Investigate the Pharmacokinetics of MK-7655 in Participants With Impaired Renal Function (MK-7655-005)	Treatment	Caffeine (DB00201) Cilastatin (DB01597) Imipenem (DB01598) Midazolam (DB00683) Omeprazole (DB00338) Relebactam (DB12377)